Kurse um 15 Minuten verzögert
Die Reihe ist auf die aktuelle Aktienzahl nach Splits umgerechnet; Dividenden sind nicht im Kurs enthalten
| Datum | Eröffnung | Hoch | Tief | Schluss | Volumen, Stück |
|---|---|---|---|---|---|
| 16. September 2026 | 120,00 | 124,41 | 119,55 | 122,58 | 1 Mio. |
| 15. September 2026 | 126,10 | 126,10 | 118,34 | 119,92 | 3 Mio. |
| 14. September 2026 | 129,50 | 130,78 | 124,58 | 125,30 | 2 Mio. |
| 11. September 2026 | 127,98 | 130,25 |
Auf Basis der Berichte bis 31. Dezember 2025
Insmed develops inhaled treatments for the lungs — the drug is delivered straight to the site.
The inhaled route creates a high concentration in the lungs with a modest burden on the body as a whole. The company's first approved drug treats a rare lung infection resistant to ordinary therapy and already brings revenue covering part of development costs.
The main bet is bronchiectasis, a chronic airway condition for which there was essentially no approved treatment. That market is an order of magnitude larger than the current one, and approval changes the company's scale. Such a stock moves on trial data and regulatory decisions rather than on results; development is funded by share issuance and debt. The company pays no dividend.
Adresse:700 US HIGHWAY 202/206, BRIDGEWATER, NJ, 08807, US
| 1,1 Mrd. |
| PFEPfizer, Inc. | 27,64 | +0,66 % | 949 Mio. |
| ABTAbbott Laboratories | 102,23 | −0,13 % | 833 Mio. |
| VRTXVertex Pharmaceuticals Incorporated | 516,34 | +0,60 % | 553 Mio. |
| BMYBristol-Myers Squibb Company | 62,84 | −1,19 % | 539 Mio. |
| 126,52 |
| 129,41 |
| 2 Mio. |
| 10. September 2026 | 127,22 | 128,85 | 124,29 | 127,28 | 3 Mio. |
| 09. September 2026 | 124,00 | 130,83 | 121,04 | 128,80 | 3 Mio. |
| 08. September 2026 | 124,78 | 127,42 | 121,38 | 124,89 | 2 Mio. |
| 04. September 2026 | 126,00 | 128,24 | 125,62 | 126,29 | 2 Mio. |
| 03. September 2026 | 126,70 | 127,09 | 124,05 | 126,68 | 2 Mio. |
| 02. September 2026 | 121,11 | 126,79 | 121,11 | 126,63 | 2 Mio. |
| 01. September 2026 | 121,95 | 122,19 | 119,52 | 121,51 | 1 Mio. |
| 31. August 2026 | 118,68 | 122,71 | 117,51 | 121,82 | 2 Mio. |
| 28. August 2026 | 120,11 | 120,66 | 117,15 | 118,54 | 2 Mio. |
| 27. August 2026 | 124,67 | 126,10 | 121,21 | 121,39 | 1 Mio. |
| 26. August 2026 | 122,89 | 125,59 | 121,64 | 124,39 | 2 Mio. |
| 25. August 2026 | 124,65 | 127,18 | 122,87 | 123,89 | 2 Mio. |
| 24. August 2026 | 125,03 | 126,11 | 122,83 | 123,98 | 1 Mio. |
| 21. August 2026 | 125,22 | 127,20 | 124,82 | 125,77 | 1 Mio. |
| 20. August 2026 | 128,36 | 130,27 | 124,60 | 125,08 | 2 Mio. |
| 19. August 2026 | 129,85 | 131,10 | 127,42 | 130,66 | 1 Mio. |